SCIENTIFIC PROGRAM

PROGRAM NEFROCARDIA

 

                       NefroCarDia PROGRAM, 16 – 18 November 2023

 

 

THURSDAY, 16 NOVEMBER:

                        08.00 – 18.00 Desk registration

08.45 – 09.00 Welcome words

            WORKSHOP ONCO – NEPHROLOGY

                                                                       

09.00 – 10.50 Session I: Chairs: Șerban Negru, Adalbert Schiller

09.00 – 09.20Why oncologists do needs a deep bond with nephrologists?  Șerban Negru, Timisoara (Ro)

09.20 – 09.40 Cardiovascular disease in oncology. CKD patients versus non-CKD patients. Are they any differences? – Mihaela Nicolcioiu, Timisoara (Ro)

09.40 – 10.00 Severe paraneoplastic flare SIADH at the beginning of chimioimmunotherapy for extended small cell pulmonary carcinoma – Sorin Săftescu, Timisoara (Ro)

10.00 – 10.20 Endocrine adverse events in treatment for kidney cancer – Dana Stoian, Timisoara (Ro)

10.20 – 10.45 Onco-nephrology: what it does really mean?! – Laura Cosmai, Milano (It)

 

10.50– 11.10 Coffee break

 

11.10 – 13.00 Session II Chairs: Dana Nagy, Oana Schiller

11.10 – 11.30 Acute kidney injury in hematopoietic stem cell transplantation - Andreea Andronesi, București (Ro)

 

11.30 – 11.50 The interrelation between cancer and kidney disease - a challenging bidirectional association Florica Gădălean, Timisoara (Ro)

11.50 – 12.20 Anticoagulation in kidney disease – practical aspects - Jecko Thachil, Manchester (UK)

12.20 – 12.35 Non-small cell lung cancer (NSCLC) -a journey through chemotherapy, TKI's, dialysis and beyondDana Nagy, Timisoara (Ro)

12.20 – 12.50 Multiple Myeloma - the Nephrologist's perspective – Oana Milaș, Timișoara (Ro)

12.50 – 13.00 Discussions

 

 


                                                                       

13.00-14.00 Lunch break

 

14.00 – 16.10 Session I Chairs: Romulus Timar, Daniel Lighezan

14.00 – 14.30 The Interplay Between Diabetes, Cardiovascular Disease, and Kidney Disease - Romulus Timar, Timisoara (Ro)

14.30 – 14.55 SGLT2 inhibitors – a treatment with two targets?! - Daniel Lighezan, Timișoara (Ro)

14.55 - 15.20 Acute kidney injury – when we call the nephrologist? - Adalbert Schiller, Timișoara (Ro)

15.20 - 15.45 We treat the heart, but we are protecting the kidney - Viviana Ivan, Timisoara (Ro)

15.45 – 16.10 Case presentations:

Membranous nephropathy in a HIV infected patient - Mădălina Bodea, Timisoara (Ro)

Acute kidney disease (AKD) after STEMI Lazăr Chișavu, Timisoara (Ro)

 

 

16.10 – 16.40 Coffee break

 

16.40 – 18.15 Session II Chairs: Adelina Mihăescu, Iulia Grosu

 

17.10 - 17.05 Nephroprotection: where do we stand know?! - Adelina Mihăescu, Timișoara (Ro)

17.35 – 17.25 Changing the perspective: evaluation of the treatment with direct-acting antiviral agents in dialysis patients in Romania - Luciana Marc, Timișoara (Ro)

17.25 – 17.45 Arterio-venous fistulae and cardiac complications – between myths and reality  - Iulia Grosu, Timișoara (Ro)

 

17.45 – 18.05 Parathyroid elastography or how to increase the diagnostic accuracy – Dana Stoian, Timișoara (Ro)

 

 

18.15– 19.15 Servier Symposium – Arterial hypertension, a complex puzzle at the intersection between different medical specialities: cardiology, diabetology, nephrology

Recommandations of the new European Guideline regarding optimal therapy for controlling hypertension and a better long term outcome. What the cardiologist is saying? – Daniel Lighezan, Timișoara (Ro)

 

The patient with diabetes and hypertension: strategies for the cardiovascular high-risk reduction. The diabetologist perspective – Bogdan Timar, Timișoara (Ro)

When the hypertensive patient evolve to CKD, what we can do? The nephrologist perspective - Adelina Mihăescu, Timișoara (Ro)

 

20.15 – Dinner

                       

FRIDAY, 17 NOVEMBER:

            08.30 – 10.30 Session I Chairs: Dorel Săndesc, Oana Schiller

08.30 – 09.00 AKI in sepsis - Dorel Săndesc, Timișoara (Ro)

09.00 – 09.30 The role of continous renal replacement therapies (CRRT) in ICU patients with AKI -  Ovidiu Bedreag, Timișoara (Ro)

09.30 – 10.00 Acute Kidney Injury in Heart Failure: How to Safely Optimise Therapy - Darren Green, Manchester (UK)

10.00 – 10.30 Do we need a nephrologist in ICU? – from bench to bedside - Oana Schiller, Timișoara (Ro)

 

 

10.30 – 11.00 Sanofi Symposium

Dislipdemia, at the intersection of multiple specialities - Adrian Apostol, Timișoara (Ro)

 

11.00- 11.30 Coffee break

 

11.30 – 13.00 Session II Chairs: Liliana Garneață, Mihai Gafencu

 

11.30 – 11.55 Neuro – cognitive impairment in CKD patients – how can we evaluate? - Liliana Gârneață, București (Ro)

11.55 – 12.15 Multidisciplinarity in transition pathways for kidney disease – from pediatric nephrology to adult nephrology - Mihai Gafencu, Ramona Stroescu, Ruxandra Jurac, Flavia Chișavu, Timișoara (Ro)

12.15 – 12.40 Case presentations

Cardiac ryhthm disturbances in advanced CKD patients - Alexandru Pescariu – Timișoara (Ro)

Patient with preeclampsia. How long should complications be monitored? - Iulia Oprea,Timișoara (Ro)

 

12.45 – 13.05 Sanofi (Rare Diseases) SymposiumChallenges in the management of Fabry nephropathy  - the experience of the Fundeni Expertise Center - Elena Rusu, București (Ro)

 

13.10 - 14.10 Lunch Symposium - Berlin – Chemie

Dialogues about hypertension

Dan Gaiță

Dragoș Cozma

 

14.10 – 15.10 Berlin-Chemie Symposium

Daniel Lighezan

Dan Darabanțiu

 

15.10 - 16.10 Session II Chairs: Stela Iurciuc, Adelina Mihăescu

 

15.10 – 15.30 COVID-19 pandemic – the perspective of the biggest hospital from the Western part of the country  - Adelina Mihăescu, Timișoara (Ro)

 

15.30 – 15.50 Thesis and antithesis in COVID-19. The experience of the “CF Timișoara” Hospital – Stela Iurciuc, Timișoara (Ro)

 

15.50 – 16.10 The dialysis patient and interdisciplinary communication during COVID-19 pandemic: what we went up against and what was learned? - Oana Schiller, Timișoara (Ro)

 

 

16.15 – 16.40 Coffee break

 

16.40– 18.30 Session III Chairs: Flaviu Bob, Diana Moldovan

16.40 – 17.10 Management of diabetic neuropathies in renal disease - Azmi Shazli, Manchester (UK)

17.10 – 17.35 Vitamin K deficiency- a trigger for vascular calcifications in CKD - Flaviu Bob, Timișoara (Ro)

17.35 – 18.00 Chronic pain in the CKD patient - Adrian Purcărea, Brașov (Ro)

18.00 – 18.25 Vascular calcifications in CKD – present and perspectives – Diana Moldovan, Cluj-Napoca (Ro)

18.30 – 19.10 Astra-Zeneca Symposium

Clinical scenarios and punctual discussions about Dapaglifozin initiation in clinical practice

Flaviu Bob, Timișoara (Ro)

Adelina Mihaescu, Timișoara (Ro)

 

 

20.00 - Dinner

 

SATURDAY, 18 NOVEMBER:

 

08.30 - 11.10 Session I Chairs: Ligia Petrica, Gener Ismail

08.30 – 08.55 Chronic kidney disease modulates the trajectories of aging in multiorgan systems - Ligia Petrica, Timișoara (Ro)

08.55 – 09.20 Mineralocorticoid receptor antagonism and nephroprotection in CKD Gener Ismail, Bucuresti (Ro)

09.20 – 09.45 Accuracy of eGFR measurements in patients with critical illness - Philip Kalra, Manchester (UK)

 

09.45 – 10.10 The new antidiabetic drugs, a paradigm shift – from glucocentric to pleiotropic effects - Nicoale Panduru, București (Ro)

10.10 – 10.25 Kidney biopsy in type 1 diabetic patient - Which are the reasons and why should we perform kidney biopsy - Oana Milaș – Timișoara (Ro)

 

10.30 – 11.00 Vifor Symposium

Efficient control pf hyperphosphatemia with sucroferric oxyhydroxide in dialysis patientsChair: Adalbert Schiller, Timișoara (Ro)

Is there a solution for the phosphate – protein dilemma? – Flaviu Bob, Timișoara (Ro)

 

Practical, what is happening with a patient treated with Velphoro ? – Adelina Mihăescu, Timișoara (Ro)

 

11.00 – 11.30 Coffee break

 

11.30 – 12.30 Astra-Zeneca Symposium

DAPA – The simple solution for three interconnected conditions – Chair: Prof. Dr. Adalbert Schiller

 

The role of DAPA before and after CKD diagnostic in DM2 patients - Romulus Timar, Timișoara (Ro)

 

DAPA efficient in heart failure independent of ejection fraction value - Daniel Lighezan, Timișoara (Ro)

 

Dapagliflozin impact - from studies to practice - Gener Ismail, București (Ro)

 

Panel discussions

 

 

 

12.30 – 13.40 Session II Chair: Philip Kalra, Oana Schiller

 

12.30 – 12.55 Influence of episodes of AKI upon progression of CKD - Philip Kalra, Manchester (UK)

 

12.55 – 13.15 Is AKD the missing link between AKI and CKD? - Lazăr Chișavu, Timișoara (Ro)

 

13.15 – 13.35 The predictive role of kinetic eGFR in the acute settings - from the pediatric nephrologist's perspective - Flavia Chișavu, Timișoara (Ro)

 

 

13.40 - 14.30 Coffee break

 

14.30 – 15.00 Stada Symposium

A new perspective in IgA nephropathy

Gener Ismail

Adalbert Schiller

 

15.00 – 17.15 Session II Chair: Adalbert Schiller, Ionuț Nistor

15.00 – 15.25 Challenges in nutritional therapy in CKD - Adrian Copcea, Cluj-Napoca (Ro)

 

15.25 – 15.50 How to read a metanalysis – Ionuț Nistor, Iași (Ro)

15.50 – 16.40 Case presentations

Pulmonary thrombembolism assesment. Is there a risk for contrast-induced nephropathy (CIN)? -

Oana Sandu, Carina Bogdan, Adrian Apostol, Timișoara (Ro)

Improving renal function in a diabetic patient with acute cardiac failure - Carina Bogdan, Oana Sandu, Adrian Apostol Timișoara (Ro)

Old vs new approach in an ANCA-associated rapidly progressive glomerulonephritis case -

Felix Maralescu, Timișoara (Ro)

Inflammation and KIM-1- risk factors of mortality in HD patients Alex Sircuța, Timișoara (Ro)

16.40 – 17.10 Non-albuminuric diabetic kidney disease – a critical review – Adalbert Schiller, Timișoara (Ro)

 

 

17.15 Closing remarks

 

 

Download Program în PDF format